The Role of Laryngopharyngeal Reflux in IPF



Status:Recruiting
Conditions:Gastroesophageal Reflux Disease
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:40 - 95
Updated:8/29/2018
Start Date:August 1, 2018
End Date:December 2020
Contact:Tara Churney, MPH
Email:ILDresearch@njhealth.org
Phone:303-398-1996

Use our guide to learn which trials are right for you!

The primary objective of this study is to show that the Supraglottic Index (SGI) is an
easily-collected index that accurately identifies the presence and severity of
laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).

The study team hypothesizes the SGI will correlate more strongly with measures of IPF
severity (at baseline and over time) than gastroesophageal reflux (GER) data derived from the
esophageal detector channels of a pH/impedance probe.

Inclusion Criteria:

- Diagnosis of IPF

- Age 40-95

- Able to read, speak, and understand English

- If subjects are currently taking medication for reflux or GERD, they much be on a
stable does for at least 4 weeks prior to consent.

Exclusion Criteria:

- Patients who do not meet all inclusion criteria

- Pregnant females
We found this trial at
1
site
1400 Jackson St
Denver, Colorado 80206
(303) 388-4461
Phone: 303-398-1996
National Jewish Health National Jewish Health is known worldwide for treatment of patients with respiratory,...
?
mi
from
Denver, CO
Click here to add this to my saved trials